SelectScience InterviewsLife Sciences

High-throughput chemo-transcriptomics for drug discovery

16 Feb 2024
High-throughput chemo-transcriptomics for drug discovery

Dr. Tim Read, Co-Founder and CTO of Arpeggio Biosciences shares how the company has been able to develop the affordable automated RNA sequencing platform GRETA (Global Reporter on Transcript Abundance) that can efficiently generate 10’s of thousands of transcriptomes in a single experiment. During the presentation, Dr. Read also shares how the Echo acoustic liquid handler from Beckman Coulter Life Sciences plays an integral part to this assay.

This video was filmed at SLAS2024.

About the company

Beckman Coulter Life Sciences logo

Beckman Coulter Life Sciences

Since 1935, the Beckman name has been synonymous with technologies that simplify and automate lab research and complex biomedical testing. Decades later, our global organization also came to embody the scientific legacy of the Coulter name. Today, Beckman Coulter Life Sciences is a trusted, worldwide resource for tools to help optimize research and manufacturing efficiency. Centrifuges. Particle counters/analyzers. Automated liquid handlers. Flow cytometers. All these products—and many more—continue to make a difference in people’s lives by improving the productivity of dedicated scientists, quality control experts and others. Visit beckman.com to learn more.

4.5/5.0
|256 Reviews

Other videos from Beckman Coulter Life Sciences

Links